Zacks Investment Research Upgrades VCA Inc. (WOOF) to Buy
VCA Inc. (NASDAQ:WOOF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday. The firm currently has a $104.00 price objective on the stock. Zacks Investment Research‘s price target suggests a potential upside of 11.86% from the stock’s previous close.
According to Zacks, “VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California. “
A number of other equities research analysts have also recently weighed in on the company. BidaskClub raised VCA from a “hold” rating to a “buy” rating in a report on Saturday, June 17th. Stifel Nicolaus reissued a “hold” rating and set a $93.00 target price on shares of VCA in a report on Friday, July 14th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $92.17.
VCA (NASDAQ:WOOF) remained flat at $92.97 during midday trading on Thursday. The company’s stock had a trading volume of 189,976 shares. The firm has a market cap of $7.56 billion, a price-to-earnings ratio of 34.94 and a beta of 1.01. The firm has a 50-day moving average price of $92.63 and a 200 day moving average price of $92.03. VCA has a 12 month low of $59.51 and a 12 month high of $93.00.
VCA (NASDAQ:WOOF) last issued its earnings results on Wednesday, July 26th. The company reported $0.96 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.02. VCA had a return on equity of 15.54% and a net margin of 8.00%. The company had revenue of $743.13 million during the quarter, compared to the consensus estimate of $735.75 million. During the same period in the previous year, the firm posted $0.87 earnings per share. Equities research analysts forecast that VCA will post $3.20 EPS for the current fiscal year.
Hedge funds have recently added to or reduced their stakes in the stock. Canada Pension Plan Investment Board raised its position in shares of VCA by 387.5% during the first quarter. Canada Pension Plan Investment Board now owns 39,000 shares of the company’s stock valued at $3,569,000 after buying an additional 31,000 shares during the last quarter. Great West Life Assurance Co. Can raised its position in shares of VCA by 6.8% during the first quarter. Great West Life Assurance Co. Can now owns 48,672 shares of the company’s stock valued at $4,452,000 after buying an additional 3,096 shares during the last quarter. Capital Fund Management S.A. acquired a new position in shares of VCA during the first quarter valued at about $2,036,000. Comerica Bank raised its position in shares of VCA by 1.9% during the first quarter. Comerica Bank now owns 62,813 shares of the company’s stock valued at $5,757,000 after buying an additional 1,153 shares during the last quarter. Finally, Swiss National Bank raised its position in shares of VCA by 1.0% during the first quarter. Swiss National Bank now owns 134,200 shares of the company’s stock valued at $12,279,000 after buying an additional 1,300 shares during the last quarter. 78.04% of the stock is owned by institutional investors and hedge funds.
VCA Inc is an animal healthcare company operating in the United States and Canada. The Company operates through five segments: animal hospitals (Animal Hospital), veterinary diagnostic laboratories (Laboratory), veterinary medical technology (Medical Technology), Vetstreet and Camp Bow Wow Franchising, Inc (Camp Bow Wow).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.